Clinical Trials | Rogel and Blondy Center for Pancreatic Cancer

Young asian lab technician uses pipette

Translating discovery to improve patient outcome

View our open clinical trials

What are clinical trials?

A clinical trial is a research study that helps us learn about new ways to prevent, find and treat cancer. The knowledge we gain from clinical trials can help improve the quality of cancer care over time. Today, thanks to patients who volunteered for studies, we have a range of treatments that can cure or delay the progression of cancer for many years. 

Researchers at the Rogel and Blondy Center for Pancreatic Cancer work together to advance laboratory discoveries into clinical trials. Numerous clinical trials testing potential new approaches are available. 

In addition, the Rogel and Blondy Center is part of Precision Promise, a network of 20 U.S. sites offering and evaluating multiple innovative options for metastatic pancreatic cancer.

View our open pancreatic cancer clinical trials.

Christie Byrne and Kim Zapor Cancer AnswerLine nurses

Questions about cancer?

Contact our Cancer AnswerLine™ at 800-865-1125. You'll talk to a nurse with years of experience in cancer care.

Learn more

News and Stories

 Susan and Richard Rogel stand with Dr. Eric Fearon the director of the Rogel Cancer Center as well as the leaders of the new Rogel and Blondy Center for Pancreatic Cancer Research
News Release

Ribbon-cutting for new pancreatic cancer program

The Rogel and Blondy Center for Pancreatic Cancer was officially launched with a special ribbon-cutting ceremony on the sixth floor of the Rogel Cancer Center.
 microscopic image with one on left saying untreated and one right saying TCDD treated. They are lit up bright green and some blue and a little red on the right
Health Lab

Study shows how smoking drives pancreatic cancer

Why smokers have a higher chance of developing pancreatic cancer and why they tend to have worse outcomes than nonsmokers, according to a new study by University of Michigan Health Rogel Cancer Center.
 blue body with red organ lit up
Health Lab

Drug targets identified for pancreatic cancer

U-M researchers have discovered that simultaneously targeting PIKfyve and KRAS-MAPK can eliminate tumors in preclinical human and mouse models.
 Susan and Richard Rogel pose next to a grand piano. Rogel is wearing a polo shirt with a block M.
News Release

Rogel Cancer Center receives $50M gift to revolutionize pancreatic cancer care, research

New Rogel and Blondy Center for Pancreatic Cancer will bring together researchers and clinicians to drive forward new treatments and improve outcomes
 doctors talking to eachother down a hallway
Health Lab

A collaborative approach to pancreatic cancer

The Rogel and Blondy Center for Pancreatic Cancer is a center of excellence in pancreatic cancer research, combining pioneering research with innovative clinical care and an array of clinical trials. Center co-director Marina Pasca di Magliano explains that the key to a robust research program and responsive care lies in collaboration.
 costas-lyssiotis
Research News

Costas Lyssiotis recognized as highly cited researcher

Costas Lyssiotis recognized as highly cited researcher

Support Pancreatic Cancer Research

Pancreatic cancer is the third leading cause of cancer-related death in the United States, for men and women. The Rogel and Blondy Center for Pancreatic Cancer Center is working to improve this cancer's outcomes.

Make a donation!